Ben-Gurion University Researchers Introduce Novel Probiotic Yogurt-Based Treatment for Inflammatory Conditions

Share this article
Share this article
BEER-SHEVA, Israel, April 8, 2021 /PRNewswire/ -- Researchers at Ben-Gurion University of the Negev (BGU) have identified novel drug candidates based on molecules isolated from probiotic yogurt for combating pathogenic bacteria and for treating various inflammatory conditions, including inflammatory bowel disease (IBD) and COVID-19 related cytokine storms. The research, led by Ms. Orit Malka, a PhD student in the laboratory of Prof. Raz Jelinek, the Vice President and Dean for Research & Development at BGU, was published in
Microbiome, a leading peer-reviewed publication.
Prof. Raz Jelinek and Ms. Orit Malka with their unique probiotic yogurt at Ben-Gurion University laboratory (Credit: Dani Machlis) (PRNewsfoto/BGN Technologies)

Related Keywords

Israel ,Tsipi Haitovsky ,Ron Apte ,Orit Malka ,Michael Meijler ,Raz Jelinek ,Ehud Zion Waldoks ,Josh Peleg ,Ariel Kushmaro ,Researchers At Ben Gurion University Of The Negev ,Deputy Spokesperson For International Media ,Dean For Research Developmentat ,Deutsche Telekom ,Ben Gurion University ,Lockheed Martin ,Vice President ,Global Media Liaison ,Zion Waldoks ,Deputy Spokesperson ,International Media ,இஸ்ரேல் ,ர்யாஸ் ஜெலினெக் ,ஜோஷ் பேழெக் ,ஆராய்ச்சியாளர்கள் இல் பென் குரியன் பல்கலைக்கழகம் ஆஃப் தி நெகெவ் ,டாய்ச் டெலிகாம் ,பென் குரியன் பல்கலைக்கழகம் ,லாக்ஹீட் மார்டின் ,துணை ப்ரெஸிடெஂட் ,சர்வதேச மீடியா ,